| Predicting free choices for abstract intentions CS Soon, AH He, S Bode, JD Haynes Proceedings of the National Academy of Sciences 110 (15), 6217-6222, 2013 | 321 | 2013 |
| Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study A He, B Merkel, JWL Brown, LZ Ryerson, I Kister, CB Malpas, S Sharmin, ... The Lancet Neurology 19 (4), 307-316, 2020 | 290 | 2020 |
| Tracking the unconscious generation of free decisions using ultra-high field fMRI S Bode, AH He, CS Soon, R Trampel, R Turner, JD Haynes PloS one 6 (6), e21612, 2011 | 246 | 2011 |
| Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis A He, T Spelman, V Jokubaitis, E Havrdova, D Horakova, M Trojano, ... JAMA neurology 72 (4), 405-413, 2015 | 128 | 2015 |
| Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke M Zou, L Churilov, A He, B Campbell, SM Davis, B Yan Journal of Clinical Neuroscience 20 (7), 984-987, 2013 | 51 | 2013 |
| Every 15-min delay in recanalization by intra-arterial therapy in acute ischemic stroke increases risk of poor outcome AH He, L Churilov, PJ Mitchell, RJ Dowling, B Yan International Journal of Stroke 10 (7), 1062-1067, 2015 | 41 | 2015 |
| Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study A He, T Spelman, A Manouchehrinia, O Ciccarelli, J Hillert, K McKay Journal of Neurology, Neurosurgery & Psychiatry 94 (4), 284-289, 2023 | 7 | 2023 |
| Rituximab infusion timing, cumulative dose, and hospitalization for COVID-19 in persons with multiple sclerosis in Sweden KA McKay, F Piehl, S Englund, A He, A Langer-Gould, J Hillert, T Frisell JAMA Network Open 4 (12), e2136697-e2136697, 2021 | 7 | 2021 |
| Early start of high-efficacy therapies improves disability outcomes over 10 years A He, B Merkel, L Zhovits, I Kister, C Malpas, S Sharmin, D Horakova, ... MULTIPLE SCLEROSIS JOURNAL 24, 497-498, 2018 | 2 | 2018 |
| Low transfer of cladribine into human milk P Datta, TW Hale, S Thiel, R Gold, K Hellwig, AH He, A Manouchehrinia, ... Multiple Sclerosis (Houndmills, Basingstoke, England), 13524585231183547 …, 2023 | 1 | 2023 |
| Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis AH He, A Manouchehrinia, A Glaser, O Ciccarelli, H Butzkueven, J Hillert, ... Multiple Sclerosis Journal 29 (9), 1126-1135, 2023 | 1 | 2023 |
| Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden FS Teni, A Machado, C Murley, A He, K Fink, H Gyllensten, A Glaser, ... Multiple Sclerosis and Related Disorders 69, 104456, 2023 | 1 | 2023 |
| 8.: Comparison of switch to fingolimod or interferon beta/glatiramer acetate as second line therapy in active multiple sclerosis A He, T Spelman, V Jokubaitis, H Butzkueven, T Kalincik, ... Journal of Clinical Neuroscience 21 (11), 2035-2036, 2014 | 1 | 2014 |
| Disentangling neurodegeneration from ageing in multiple sclerosis: the brain-predicted disease duration gap G Pontillo, F Prados, J Colman, B Kanber, O Abdel-Mannan, S Al-Araji, ... medRxiv, 2024.01. 02.23300497, 2024 | | 2024 |
| Understanding the Relationship between Education and Clinical Outcomes in Multiple Sclerosis AL Ahmad, AJ Thompson, A Toosy, A Aojula, A Bianchi, D Chard, ... | | 2023 |
| Increased risk of secondary progression in associated with sustained decrease of income A Christakou, A He, L Stawiarz, T Spelman, A Manouchehrinia, E Friberg, ... MULTIPLE SCLEROSIS JOURNAL 29, 777-777, 2023 | | 2023 |
| Motor and cognitive correlates of brain and spinal cord volumetric MRI measures in multiple sclerosis W Hamed, M Moccia, F Prados, G Pontillo, S Al-Araji, A Aojula, A Bianchi, ... MULTIPLE SCLEROSIS JOURNAL 29, 830-832, 2023 | | 2023 |
| Investigating association between OCT, MRI and cognition in MS R Christensen, A Jolly, C Yam, A Toosy, W Hamed, P Sood, A He, ... MULTIPLE SCLEROSIS JOURNAL 29, 875-876, 2023 | | 2023 |
| Investigating clinical and radiological correlates with OCT in MS patients commencing disease-modifying therapy P Sood, W Hamed, R Christensen, D Champsas, E Panella, A Toorop, ... MULTIPLE SCLEROSIS JOURNAL 29, 879-880, 2023 | | 2023 |
| Clinic-level quality of care affects patient outcomes in relapse-onset MS A He, A Manouchehrinia, H Butzkueven, O Ciccarelli, A Glaser, J Hillert, ... MULTIPLE SCLEROSIS JOURNAL 29, 169-170, 2023 | | 2023 |
